Higgs mediated Double Flavor Violating top decays in Effective Theories

The possibility of detecting double flavor violating top quark transitions at future colliders is explored in a model-independent manner using the effective Lagrangian approach through the $t \to u_i\tau \mu$ ($u_i=u,c$) decays. A Yukawa sector that contemplates $SU_L(2)\times U_Y(1)$ invariants of up to dimension six is proposed and used to derive the most general flavor violating and CP violating $q_iq_jH$ and $l_il_jH$ vertices of renormalizable type. Low-energy data, on high precision measurements, and experimental limits are used to constraint the $tu_iH$ and $H\tau \mu$ vertices and then used to predict the branching ratios for the $t \to u_i\tau \mu$ decays. It is found that this branching ratios may be of the order of $10^{-4}-10^{-5}$, for a relative light Higgs boson with mass lower than $2m_W$, which could be more important than those typical values found in theories beyond the standard model for the rare top quark decays $t\to u_iV_iV_j$ ($V_i=W,Z,\gamma, g$) or $t\to u_il^+l^-$. %% LHC experiments, by using a total integrated luminosity of $\rm 3000 fb^{-1}$ of data, will be able to rule out, at 95% C.L., DFV top quark decays up to a Higgs mass of 155 GeV/$c^2$ or discover such a process up to a Higgs mass of 147 GeV/$c^2$.Comment: 24 pages, 11 figure

Radiative Shocks in Rotating Accretion Flows around Black Holes

It is well known that the rotating inviscid accretion flows with adequate injection parameters around black holes could form shock waves close to the black holes, after the flow passes through the outer sonic point and can be virtually stopped by the centrifugal force. We examine numerically such shock waves in 1D and 2D accretion flows, taking account of cooling and heating of the gas and radiation transport. The numerical results show that the shock location shifts outward compared with that in the adiabatic solutions and that the more rarefied ambient density leads to the more outward shock location. In the 2D-flow, we find an intermediate frequency QPO behavior of the shock location as is observed in the black hole candidate GRS 1915+105.Comment: 11pages, 5 Postscript figures, to appear in PASJ, Vol.56, No.3, 200

Medical Data Architecture Platform and Recommended Requirements for a Medical Data System for Exploration Missions

The Medical Data Architecture (MDA) project supports the Exploration Medical Capability (ExMC) risk to minimize or reduce the risk of adverse health outcomes and decrements in performance due to in-flight medical capabilities on human exploration missions. To mitigate this risk, the ExMC MDA project addresses the technical limitations identified in ExMC Gap Med 07: We do not have the capability to comprehensively process medically- relevant information to support medical operations during exploration missions. This gap identifies that the current in-flight medical data management includes a combination of data collection and distribution methods that are minimally integrated with on-board medical devices and systems. Furthermore, there are a variety of data sources and methods of data collection. For an exploration mission, the seamless management of such data will enable a more medically autonomous crew than the current paradigm of medical data management on the International Space Station. ExMC has recognized that in order to make informed decisions about a medical data architecture framework, current methods for medical data management must not only be understood, but an architecture must also be identified that provides the crew with actionable insight to medical conditions. This medical data architecture will provide the necessary functionality to address the challenges of executing a self-contained medical system that approaches crew health care delivery without assistance from ground support. Hence, the products derived from the third MDA prototype development will directly inform exploration medical system requirements for Level of Care IV in Gateway missions. In fiscal year 2019, the MDA project developed Test Bed 3, the third iteration in a series of prototypes, that featured integrations with cognition tool data, ultrasound image analytics and core Flight Software (cFS). Maintaining a layered architecture design, the framework implemented a plug-in, modular approach in the integration of these external data sources. An early version of MDA Test Bed 3 software was deployed and operated in a simulated analog environment that was part of the Next Space Technologies for Exploration Partnerships (NextSTEP) Gateway tests of multiple habitat prototypes. In addition, the MDA team participated in the Gateway Test and Verification Demonstration, where the MDA cFS applications was integrated with Gateway-in-a-Box software to send and receive medically relevant data over a simulated vehicle network. This software demonstration was given to ExMC and Gateway Program stakeholders at the NASA Johnson Space Center Integrated Power, Avionics and Software (iPAS) facility. Also, the integrated prototypes served as a vehicle to provide Level 5 requirements for the Crew Health and Performance Habitat Data System for Gateway Missions (Medical Level of Care IV). In the upcoming fiscal year, the MDA project will continue to provide systems engineering and vertical prototypes to refine requirements for medical Level of Care IV and inform requirements for Level of Care V

Study of the lepton flavor-violating Z′→τμZ'\to\tau\mu decay

The lepton flavor violating $Z^{\prime}\to\tau\mu$ decay is studied in the context of several extended models that predict the existence of the new gauge boson named $Z^\prime$. A calculation of the strength of the lepton flavor violating $Z^\prime\mu\tau$ coupling is presented by using the most general renormalizable Lagrangian that includes lepton flavor violation. We used the experimental value of the muon magnetic dipole moment to bound this coupling, from which the $\mathrm{Re}(\Omega_{L\mu\tau}\Omega^\ast_{R\mu\tau})$ parameter is constrained and it is found that $\mathrm{Re}(\Omega_{L\mu\tau}\Omega^\ast_{R\mu\tau})\sim 10^{-2}$ for a $Z^\prime$ boson mass of 2 TeV. Alongside, we employed the experimental restrictions over the $\tau\to\mu\gamma$ and $\tau\to\mu\mu^+\mu^-$ processes in the context of several models that predict the existence of the $Z^\prime$ gauge boson to bound the mentioned coupling. The most restrictive bounds come from the calculation of the three-body decay. For this case, it was found that the most restrictive result is provided by a vector-like coupling, denoted as $|\Omega_{\mu\tau}|^2$, for the $Z_\chi$ case, finding around $10^{-2}$ for a $Z^\prime$ boson mass of 2 TeV. We used this information to estimate the branching ratio for the $Z^\prime\to\tau\mu$ decay. According to the analyzed models the least optimistic result is provided by the Sequential $Z$ model, which is of the order of $10^{-2}$ for a $Z^\prime$ boson mass around 2 TeV.Comment: Revised versio

NASA-Navy Telemedicine: Autogenic Feedback Training Exercises for Motion Sickness

Airsickness is the most significant medical condition affecting naval aviation training. A 2001 study showed that airsickness was reported in 81% of naval aviation students and was associated with 82% of below average flight scores. The cost to a single training air-wing was over $150,000 annually for fuel and maintenance costs alone. Resistent cases are sent to the Naval Aerospace Medical Institute (NAMI) for evaluation and desensitization in the self-paced airsickness desensitization (SPAD) program. This approach is 75$2,000 per student trained. 3. Reduce aviation training attrition. 4. Provide standardization of multi-location motion sickness training. 5. Future tri-service initiatives. 6. Data to NASA and Navy for QA and research opportunities

Short-term effects of focal muscle vibration on motor recovery after acute stroke: a pilot randomized sham-controlled study

Repetitive focal muscle vibration (rMV) is known to promote neural plasticity and long-lasting motor recovery in chronic stroke patients. Those structural and functional changes within the motor network underlying motor recovery occur in the very first hours after stroke. Nonetheless, to our knowledge, no rMV-based studies have been carried out in acute stroke patients so far, and the clinical benefit of rMV in this phase of stroke is yet to be determined. The aim of this randomized double-blind sham-controlled study is to investigate the short-term effect of rMV on motor recovery in acute stroke patients. Out of 22 acute stroke patients, 10 were treated with the rMV (vibration group–VG), while 12 underwent the sham treatment (control group–CG). Both treatments were carried out for 3 consecutive days, starting within 72 h of stroke onset; each daily session consisted of three 10-min treatments (for each treated limb), interspersed with a 1-min interval. rMV was delivered using a specific device (Cro®System, NEMOCO srl, Italy). The transducer was applied perpendicular to the target muscle's belly, near its distal tendon insertion, generating a 0.2–0.5 mm peak-to-peak sinusoidal displacement at a frequency of 100 Hz. All participants also underwent a daily standard rehabilitation program. The study protocol underwent local ethics committee approval (ClinicalTrial.gov NCT03697525) and written informed consent was obtained from all of the participants. With regard to the different pre-treatment clinical statuses, VG patients showed significant clinical improvement with respect to CG-treated patients among the NIHSS (p < 0.001), Fugl-Meyer (p = 0.001), and Motricity Index (p < 0.001) scores. In addition, when the upper and lower limb scales scores were compared between the two groups, VG patients were found to have a better clinical improvement at all the clinical end points. This study provides the first evidence that rMV is able to improve the motor outcome in a cohort of acute stroke patients, regardless of the pretreatment clinical status. Being a safe and well-tolerated intervention, which is easy to perform at the bedside, rMV may represent a valid complementary non-pharmacological therapy to promote motor recovery in acute stroke patients

Methods for assessment of keel bone damage in poultry

Keel bone damage (KBD) is a critical issue facing the laying hen industry today as a result of the likely pain leading to compromised welfare and the potential for reduced productivity. Recent reports suggest that damage, while highly variable and likely dependent on a host of factors, extends to all systems (including battery cages, furnished cages, and non-cage systems), genetic lines, and management styles. Despite the extent of the problem, the research community remains uncertain as to the causes and influencing factors of KBD. Although progress has been made investigating these factors, the overall effort is hindered by several issues related to the assessment of KBD, including quality and variation in the methods used between research groups. These issues prevent effective comparison of studies, as well as difficulties in identifying the presence of damage leading to poor accuracy and reliability. The current manuscript seeks to resolve these issues by offering precise definitions for types of KBD, reviewing methods for assessment, and providing recommendations that can improve the accuracy and reliability of those assessment